PGRMC Proteins Are Coming of Age: A Special Issue on the Role of PGRMC1 and PGRMC2 in Metabolism and Cancer Biology
- PMID: 33572771
- PMCID: PMC7866220
- DOI: 10.3390/cancers13030512
PGRMC Proteins Are Coming of Age: A Special Issue on the Role of PGRMC1 and PGRMC2 in Metabolism and Cancer Biology
Abstract
This is a preface by the guest editors of the special issue of Cancers featuring the biology of progesterone (P4) receptor membrane component (PGRMC) proteins as it relates to metabolism and cancer [...].
Conflict of interest statement
M.A.C. is scientific advisor to and minor shareholder of Cognition Therapeutics, a company developing sigma-2 receptor ligands against Alzheimer’s disease. This work was performed independently of and without input from the company. The authors declare that they have no other competing interests.
References
-
- Neubauer H., Clare S.E., Kurek R., Fehm T., Wallwiener D., Sotlar K., Nordheim A., Wozny W., Schwall G.P., Poznanovic S., et al. Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection. Electrophoresis. 2006;27:1840–1852. doi: 10.1002/elps.200500739. - DOI - PubMed
-
- Neubauer H., Clare S.E., Wozny W., Schwall G.P., Poznanovic S., Stegmann W., Vogel U., Sotlar K., Wallwiener D., Kurek R., et al. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1. Breast Cancer Res. BCR. 2008;10:R85. doi: 10.1186/bcr2155. - DOI - PMC - PubMed
-
- Cahill M., Schrattenholz A., Kurek R., Wallwiener D., Neubauer H., Clare S. Phosphorylated or Non-Phosphorylated MPR as Diagnostic Marker or Therapeutic Target, in: EPO (Ed.), ProteoSys AG, Mainz, Germany. WO2007039189. Patent Application. 2007 Apr 12; Priority 20050926.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
